Abstract
According to "Japanese Generic Market Forecast to 2013", a new research report
by RNCOS, Japan promises to be one of the most lucrative generic markets in
the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR
of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government,
which in a desperate bid to limit its healthcare costs, is introducing a
number of generic-friendly policies. Other factors such as a large number of
patent expiries and the largely un-penetrated nature of the market are also
contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the
top six manufacturers accounting for 56% of the total market in 2007. But
opening up of the market and introduction of a number of generic-friendly
reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number
challenges to deal with. Generic drugs are still regarded as cheap, low
quality alternatives of branded drugs. Thus, both physicians and patients are
skeptic regarding their safety and efficacy. A number of awareness and
educational programs, however, are expected to increase their awareness in
future.
Despite these challenges, our forecast models suggest that the generic drugs
market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in
Japan. It investigates both the past and present trends in the generic market,
but its focus is on the future trends shaping the industry. The report also
investigates the performance of various players in the Japanese pharmaceutical
and generic markets, and analyzes the competitive landscape in these markets.
Based on various present and future indicators, the future scenario of the
market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese
pharmaceutical and generic markets. This section describes market shares and
growth of key pharmaceutical and generic players in Japan. Profiles of the top
six generic manufacturers have been provided in the report.
| 
View Cart
